Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Boulet

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Brain : a Journal of Neurology|September 15, 2007
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recoveryStéphanie Mounayar, Sabrina Boulet, Dominique Tandé, et al.
Biology Methods & Protocols|May 13, 2020
Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkersThibault Dufourd, Noémie Robil, David Mallet, et al.
The European Journal of Neuroscience|February 18, 2025
Unilateral and Bilateral Subthalamic Deep Brain Stimulation Differently Favour Apathy in Parkinson's DiseaseYvan M Vachez, Marie Bahout, Robin Magnard, et al.
Molecular Psychiatry|November 14, 2022
Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol useRaphaël Goutaudier, Fanny Joly, David Mallet, et al.
Translational Psychiatry|February 9, 2024
Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networksRobin Magnard, Maxime Fouyssac, Yvan M Vachez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2008
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysisSabrina Boulet, Stéphanie Mounayar, Annie Poupard, et al.
The Journal of Clinical Investigation|December 16, 2021
A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal modelsDavid Mallet, Thibault Dufourd, Mélina Decourt, et al.
Plos One|January 10, 2013
IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primatesRomina Aron Badin, Brigitte Spinnewyn, Marie-Claude Gaillard, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Brain : a Journal of Neurology|September 15, 2007
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recoveryStéphanie Mounayar, Sabrina Boulet, Dominique Tandé, et al.
Biology Methods & Protocols|May 13, 2020
Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkersThibault Dufourd, Noémie Robil, David Mallet, et al.
The European Journal of Neuroscience|February 18, 2025
Unilateral and Bilateral Subthalamic Deep Brain Stimulation Differently Favour Apathy in Parkinson's DiseaseYvan M Vachez, Marie Bahout, Robin Magnard, et al.
Molecular Psychiatry|November 14, 2022
Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol useRaphaël Goutaudier, Fanny Joly, David Mallet, et al.
Translational Psychiatry|February 9, 2024
Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networksRobin Magnard, Maxime Fouyssac, Yvan M Vachez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2008
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysisSabrina Boulet, Stéphanie Mounayar, Annie Poupard, et al.
The Journal of Clinical Investigation|December 16, 2021
A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal modelsDavid Mallet, Thibault Dufourd, Mélina Decourt, et al.
Plos One|January 10, 2013
IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primatesRomina Aron Badin, Brigitte Spinnewyn, Marie-Claude Gaillard, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Pageof 2